Related Experiment Video
Updated: Aug 23, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Effects of TGF beta1 autocrine blockage on osteosarcoma cells
Yong Liu1, Qi-Xin Zheng, Jing-Yuan Du
1Department of Orthopaedics, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022. lw7812@21cn.com
Objective:
To evaluate the effects of transforming growth factor beta1 (TGFbeta1) autocrine blockage on proliferation activity and drug sensitivity of osteosarcoma. METHODS; Northern blot, MTT determination, and 3H thymidine incorporation were used to investigate the effects of antisense TGF beta1 gene on osteosarcoma.
Results:
The proliferation of osteosarcoma cells transfected by antisense TGF beta1 gene was suppressed markedly, and adriamycin sensitivity was significantly increased.
Conclusion:
Blockage of osteosarcoma cells TGF beta1 autocrine loop inhibits cell proliferation and enhances chemotherapy sensitivity.
Insights
Blocking transforming growth factor beta1 (TGFbeta1) in osteosarcoma cells reduced proliferation and increased sensitivity to chemotherapy drugs like adriamycin.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma is a primary bone cancer with limited treatment options.
- Transforming growth factor beta1 (TGFbeta1) signaling plays a role in tumor progression.
- Autocrine TGFbeta1 signaling may contribute to osteosarcoma's aggressive phenotype.
Purpose of the Study:
- To investigate the impact of blocking TGFbeta1 autocrine signaling on osteosarcoma cell proliferation.
- To determine if inhibiting TGFbeta1 affects the sensitivity of osteosarcoma cells to chemotherapy.
Main Methods:
- Utilized Northern blot to assess gene expression.
- Employed MTT assays to measure cell proliferation.
- Used 3H thymidine incorporation to evaluate DNA synthesis.
- Investigated the effects of antisense TGFbeta1 gene transfection.
Main Results:
- Transfection with antisense TGFbeta1 gene significantly suppressed osteosarcoma cell proliferation.
- Adriamycin sensitivity was markedly increased in osteosarcoma cells with blocked TGFbeta1 signaling.
- Autocrine TGFbeta1 loop blockage demonstrated a direct inhibitory effect on tumor cell growth.
Conclusions:
- Inhibiting the TGFbeta1 autocrine loop is a promising strategy to reduce osteosarcoma growth.
- Blocking TGFbeta1 enhances the efficacy of chemotherapy agents in osteosarcoma treatment.
- Targeting TGFbeta1 signaling could improve therapeutic outcomes for osteosarcoma patients.
